TABLE 4.
Risk of adverse pregnancy outcomes in women with stage 1 hypertension to the normotension, respectively, in the control or aspirin group when initialed at or before 16 weeks of gestation
| Control | Aspirin | |||||
|---|---|---|---|---|---|---|
|
Normotension 95 |
Stage 1 hypertension 49 |
p value |
Normotension 95 |
Stage 1 hypertension 44 |
p value | |
| Preeclampsia | 1.00 (ref) | 3.960 (1.299–12.074) | .016 | 1.00 (ref) | 0.921 (0.140–6.070) | .932 |
| Delivery at <37 gestational weeks | 1.00 (ref) | 3.281 (0.791–13.617) | .102 | 1.00 (ref) | 1.828 (0.101–32.955) | .683 |
| Delivery at ≥37 gestational weeks | 1.00 (ref) | 4.359 (0.788–24.109) | .092 | 1.00 (ref) | 0.584 (0.050–6.887) | .669 |
| Preterm birth | 1.00 (ref) | 1.157 (0.458–2.926) | .758 | 1.00 (ref) | 0.432 (0.087–2.148) | .305 |
| Placental abruption | 1.00 (ref) | 0.731 (0.179–2.990) | .663 | 1.00 (ref) | 1.305 (0.353–4.823) | .690 |
| Postpartum hemorrhage | 1.00 (ref) | 0.134 (0.016–1.122) | .064 | 1.00 (ref) | 0.999 (0.274–3.648) | .999 |
| SGA (<10th percentile) | 1.00 (ref) | 1.732 (0.424–7.076) | .444 | 1.00 (ref) | 0.392 (0.076–2.013) | .262 |
The data were shown as aOR (95% CI). The normotension group, respectively, in the control group or the aspirin group was referent.
Abbreviations: aOR, adjusted odds ratio, adjusted for maternal age, prepregnancy body mass index, nulliparity; CI, confidence interval; NA, not applicable; SGA, small for gestational age.